Similar articles

• Effective surgical adjuvant therapy for high-risk rectal carcinoma.

  Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, et al. Krook JE, et al. N Engl J Med. 1991 Mar 14;324(11):709-15. doi: 10.1056/NEJM199103143241101. N Engl J Med. 1991. PMID: 1997835 Clinical Trial.
• Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.

  O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA. O'Connell MJ, et al. N Engl J Med. 1994 Aug 25;331(8):502-7. doi: 10.1056/NEJM199408253310803. N Engl J Med. 1994. PMID: 8041415 Clinical Trial.
• [Adjuvant treatment of resected colon cancers using a 5-fluorouracil-levamisole combination].

  Ducreux M. Ducreux M. Gastroenterol Clin Biol. 1991;15(8-9):665-7. Gastroenterol Clin Biol. 1991. PMID: 1752386 French. No abstract available.
• [Choice of treatment in rectal cancer. Consensus Conference, Chamber of Commerce and Industry, Paris, December 1-2, 1994].

  [No authors listed] [No authors listed] Ann Gastroenterol Hepatol (Paris). 1995 Sep;31(4):226-30, 233-6. Ann Gastroenterol Hepatol (Paris). 1995. PMID: 7486820 Review. French. No abstract available.
• [Rectal cancer: treatment and results].

  Luna Pérez P. Luna Pérez P. Rev Invest Clin. 2001 Jan-Feb;53(1):65-76. Rev Invest Clin. 2001. PMID: 11332053 Review. Spanish. No abstract available.